EP3263588 - ISOLATED STAPHYLOCOCCUS-SPECIFIC SOLUBLE BINDING MOLECULE [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 03.12.2019 Database last updated on 03.09.2024 | |
Former | Request for examination was made Status updated on 06.07.2018 | ||
Former | The application has been published Status updated on 01.12.2017 | Most recent event Tooltip | 01.08.2023 | Change - representative | Applicant(s) | For all designated states The Rockefeller University 1230 York Avenue New York, NY 10065 / US | [2018/01] | Inventor(s) | 01 /
FISCHETTI, Vincent, A 448 Joan Court West Hempstead New York, NY 11552 / US | 02 /
DANIEL, Anu 12419 Main Campus Drive Lexington Massachusetts, MA 02421 / US | 03 /
EULER, Chad 1230 York Avenue New York, NY 10021 / US | [2018/01] | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
Former [2018/01] | Ruscoe, Peter James Sagittarius IP Three Globeside Fieldhouse Lane Marlow Buckinghamshire SL7 1HZ / GB | Application number, filing date | 17158578.9 | 01.07.2009 | [2018/01] | Priority number, date | US20080078277P | 03.07.2008 Original published format: US 78277 P | [2018/01] | Previously filed application, date | WO2009US49349 | 01.07.2009 | [2018/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3263588 | Date: | 03.01.2018 | Language: | EN | [2018/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 01.12.2017 | Classification | IPC: | C07K14/005 | [2018/01] | CPC: |
C12N9/2462 (EP,US);
A01N63/00 (US);
A01N63/50 (EP,US);
A61P31/04 (EP);
C07K14/005 (EP,US);
A61K38/00 (EP,US);
A61K38/47 (EP,US);
C07K2319/00 (EP,US);
C12N2795/10322 (EP,US);
Y02A50/30 (EP)
(-)
| C-Set: |
A01N63/50, A01N63/40 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2018/32] |
Former [2018/01] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Title | German: | MOLÉCULE ISOLÉE SOLUBLE SE LIANT SPÉCIFIQUEMENT À STAPHYLOCOCCUS | [2018/01] | English: | ISOLATED STAPHYLOCOCCUS-SPECIFIC SOLUBLE BINDING MOLECULE | [2018/01] | French: | ISOLIERTES AN STAPHYLOCOCCUS SPEZIFISCH BINDENDES MOLEKÜL | [2018/01] | Examination procedure | 28.02.2017 | Date on which the examining division has become responsible | 03.07.2018 | Amendment by applicant (claims and/or description) | 03.07.2018 | Examination requested [2018/32] | 06.12.2019 | Despatch of a communication from the examining division (Time limit: M06) | 18.05.2020 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP09774409.8 / EP2307557 | Fees paid | Renewal fee | 28.02.2017 | Renewal fee patent year 03 | 28.02.2017 | Renewal fee patent year 04 | 28.02.2017 | Renewal fee patent year 05 | 28.02.2017 | Renewal fee patent year 06 | 28.02.2017 | Renewal fee patent year 07 | 28.02.2017 | Renewal fee patent year 08 | 24.07.2017 | Renewal fee patent year 09 | 23.07.2018 | Renewal fee patent year 10 | 29.07.2019 | Renewal fee patent year 11 | 27.07.2020 | Renewal fee patent year 12 | 27.07.2021 | Renewal fee patent year 13 | 27.07.2022 | Renewal fee patent year 14 | 27.07.2023 | Renewal fee patent year 15 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO9708553 (UNIV CALIFORNIA [US]) [Y] 1-11 * page 8, lines 19-23 * * page 71, line 12 - page 72, line 2 * * claim 62 *; | [E]WO2010041970 (LUSOMEDICAMENTA S A [PT], et al) [E] 1,6 * The query sequence SEQ ID NO:1 has 100 % identity (100 % similarity) over 94 positions in a common overlap (range (q:s): 1-94:158-251) with subject GSP:AXX86830 (length: 251) from WO2010041970-A2 published on 2010-04-15. *; | [E]WO2010090542 (TECHNOPHAGE INVESTIGACAO E DES [PT], et al) [E] 1,6 * The query sequence SEQ ID NO:1 has 100 % identity (100 % similarity) over 94 positions in a common overlap (range (q:s): 1-94:158-251) with subject GSP:AYG90537 (length: 251) from WO2010090542-A2 published on 2010-08-12. The query sequence SEQ ID NO:1 has 100 % identity (100 % similarity) over 94 positions in a common overlap (range (q:s): 1-94:158-251) with subject GSP:AYG90471 (length: 255) from WO2010090542-A2 published on 2010-08-12. *; | [X] - "SubName: Full=ORF016;", UniProt, (20050607), Database accession no. Q4ZE09, URL: EBI, XP002669507 [X] 1,6 * the whole document * | [X] - KWAN TONY ET AL, "The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages", PROCEEDINGS NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 102, no. 14, doi:10.1073/PNAS.0501140102, ISSN 0027-8424, (20050405), pages 5174 - 5179, (20050323), XP009136820 [X] 1,6 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.0501140102 | [Y] - AHMED ET AL, "Evaluation of cell wall binding domain of Staphylococcus aureus autolysin as affinity reagent for bacteria and its application to bacterial detection", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, ELSEVIER, AMSTERDAM, NL, (20070701), vol. 104, no. 1, doi:10.1263/JBB.104.55, ISSN 1389-1723, pages 55 - 61, XP022196798 [Y] 1-11 * the whole document * * in particular the abstract * DOI: http://dx.doi.org/10.1263/jbb.104.55 | [Y] - LOESSNER ET AL, "Bacteriophage endolysins - current state of research and applications", CURRENT OPINION IN MICROBIOLOGY, CURRENT BIOLOGY LTD, GB, vol. 8, no. 4, ISSN 1369-5274, (20050801), pages 480 - 487, (20050801), XP027848308 [Y] 1-11 * page 485, column l, paragraph 1 * | [A] - CROUX C ET AL, "INTERCHANGE OF FUNCTIONAL DOMAINS SWITCHES ENZYME SPECIFICITY: CONSTRUCTION OF A CHIMERIC PNEUMOCOCCAL-CLOSTRIDIAL CELL WALL LYTIC ENZYME", MOLECULAR MICROBIOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, (19930101), vol. 9, no. 5, doi:10.1111/J.1365-2958.1993.TB01231.X, ISSN 0950-382X, pages 1019 - 1025, XP000992669 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1111/j.1365-2958.1993.tb01231.x | by applicant | - American Journal of Infection Control, vol. 31, pages 481 - 498 | - MASSEY RC; HORSBURGH MJ; LINA G; HOOK M; RECKER M., "The evolution and maintenance of virulence in Staphylococcus aureus: a role for host-to-host transmission?", Nat Rev Microbiol, (20060000), vol. 4, no. 12, pages 953 - 8 | - GILL SR; FOUTS DE; ARCHER GL; MONGODIN EF; DEBOY RT; RAVEL J; PAULSEN IT; KOLONAY JF; BRINKAC L; BEANAN M, "Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain", J Bacteriol, (20050000), vol. 187, no. 7, doi:doi:10.1128/JB.187.7.2426-2438.2005, pages 2426 - 38, XP002463146 DOI: http://dx.doi.org/10.1128/JB.187.7.2426-2438.2005 | - AKSOY DY; UNAL S., "New antimicrobial agents for the treatment of Gram-positive bacterial infections", Clin Microbiol Infect, (20080000), vol. 14, no. 5, pages 411 - 20 | - TSIODRAS S; GOLD HS; SAKOULAS G; ELIOPOULOS GM; WENNERSTEN C; VENKATARAMAN L; MOELLERING RC; FERRARO MJ., "Linezolid resistance in a clinical isolate of Staphylococcus aureus", Lancet, (20010000), vol. 358, no. 9277, doi:doi:10.1016/S0140-6736(01)05410-1, pages 207 - 8, XP005017531 DOI: http://dx.doi.org/10.1016/S0140-6736(01)05410-1 | - MANGILI A; BICA I; SNYDMAN DR; HAMER DH., "Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia", Clin Infect Dis, (20050000), vol. 40, no. 7, pages 1058 - 60 | - SKIEST DJ., "Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin", J Clin Microbiol, (20060000), vol. 44, no. 2, pages 655 - 6 | - FISCHETTI VA; NELSON D; SCHUCH R., "Reinventing phage therapy: are the parts greater than the sum?", Nat Biotechnol, (20060000), vol. 24, no. 12, doi:doi:10.1038/nbt1206-1508, pages 1508 - 11, XP002624151 DOI: http://dx.doi.org/10.1038/nbt1206-1508 | - SHEEHAN MM; GARCIA JL; LOPEZ R; GARCIA P., "Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling", FEMS Microbiol Lett, (19960000), vol. 140, no. 1, doi:doi:10.1016/0378-1097(96)00151-6, pages 23 - 8, XP000992665 DOI: http://dx.doi.org/10.1016/0378-1097(96)00151-6 | - LOPEZ R GE; GARCIA P; GARCIA JL., "The pneumococcal cell wall degrading enzymes: a modular design to create new lysins?", Microb Drug Res, (19970000), vol. 3, pages 199 - 211 | - CROUX C; RONDA C; LOPEZ R; GARCIA JL., "Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme", Mol Microbiol, (19930000), vol. 9, no. 5, doi:doi:10.1111/j.1365-2958.1993.tb01231.x, pages 1019 - 25, XP000992669 DOI: http://dx.doi.org/10.1111/j.1365-2958.1993.tb01231.x | - DONOVAN DM; DONG S; GARRETT W; ROUSSEAU GM; MOINEAU S; PRITCHARD DG., "Peptidoglycan hydrolase fusions maintain their parental specificities", Appl Environ Microbiol, (20060000), vol. 72, no. 4, pages 2988 - 96 | - NELSON D; LOOMIS L; FISCHETTI VA., "Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme", Proc Natl Acad Sci U S A, (20010000), vol. 98, no. 7, doi:doi:10.1073/pnas.061038398, pages 4107 - 12, XP002165225 DOI: http://dx.doi.org/10.1073/pnas.061038398 | - LOEFFLER JM; NELSON D; FISCHETTI VA, "Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase", Science, (20010000), vol. 294, no. 5549, doi:doi:10.1126/science.1066869, pages 2170 - 2, XP002392510 DOI: http://dx.doi.org/10.1126/science.1066869 | - SCHUCH R; NELSON D; FISCHETTI VA, "A bacteriolytic agent that detects and kills Bacillus anthracis", Nature, (20020000), vol. 418, no. 6900, doi:doi:10.1038/nature01026, pages 884 - 9, XP002903133 DOI: http://dx.doi.org/10.1038/nature01026 | - YOONG P; SCHUCH R; NELSON D; FISCHETTI VA., "Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium", J Bacteriol, (20040000), vol. 186, no. 14, pages 4808 - 12, XP009136845 | - CHENG Q; NELSON D; ZHU S; FISCHETTI VA., "Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme", Antimicrob Agents Chemother, (20050000), vol. 49, no. 1, doi:doi:10.1128/AAC.49.1.111-117.2005, pages 111 - 7, XP002503533 DOI: http://dx.doi.org/10.1128/AAC.49.1.111-117.2005 | - RASHEL M; UCHIYAMA J; UJIHARA T; UEHARA Y; KURAMOTO S; SUGIHARA S; YAGYU K; MURAOKA A; SUGAI M; HIRAMATSU K, "Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11", J Infect Dis, (20070000), vol. 196, no. 8, doi:doi:10.1086/521305, pages 1237 - 47, XP009100811 DOI: http://dx.doi.org/10.1086/521305 | - FINNIN; MORGAN, J Pharm Sci, (19991000), vol. 88, no. 10, pages 955 - 958 | - "The use of interspecies scaling in toxicokinetics", MORDENTI, J.; CHAPPELL, W. et al., Toxicokinetics and New Drug Development, Pergamon Press, (19890000), pages 42 - 96 | - LUE et al., J. Biol. Chem., (20060000), vol. 281, no. 1, pages 549 - 58 | - KLUYTMANS, J.; A. VAN BELKUM., "Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks", Clin Microbiol Rev, (19970000), vol. 10, no. 3, pages 505 - 20 |